SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:prod.swepub.kib.ki.se:142825850"
 

Search: id:"swepub:oai:prod.swepub.kib.ki.se:142825850" > European reference ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • van de Laar, IMBH (author)

European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants

  • Article/chapterEnglish2019

Publisher, publication year, extent ...

  • 2019-11-21
  • Springer Science and Business Media LLC,2019

Numbers

  • LIBRIS-ID:oai:prod.swepub.kib.ki.se:142825850
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:142825850URI
  • https://doi.org/10.1186/s13023-019-1186-2DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • The ACTA2 gene encodes for smooth muscle specific α-actin, a critical component of the contractile apparatus of the vascular smooth muscle cell. Pathogenic variants in the ACTA2 gene are the most frequently encountered genetic cause of non-syndromic hereditary thoracic aortic disease (HTAD). Although thoracic aortic aneurysm and/or dissection is the main clinical manifestation, a variety of occlusive vascular disease and extravascular manifestations occur in ACTA2-related vasculopathy. Current data suggest possible mutation-specific manifestations of vascular and extra-aortic traits.Despite its relatively high prevalence, comprehensive recommendations on the care of patients and families with pathogenic variants in ACTA2 have not yet been established. We aimed to develop a consensus document to provide medical guidance for health care professionals involved in the diagnosis and treatment of patients and relatives with pathogenic variants in ACTA2.The HTAD Working Group of the European Reference Network for Rare Vascular Diseases (VASCERN) convened to review current literature and discuss expert opinions on clinical management of ACTA2 related vasculopathy. This consensus statement summarizes our recommendations on diagnosis, monitoring, treatment, pregnancy, genetic counselling and testing in patients with ACTA2-related vasculopathy. However, there is a clear need for additional prospective multicenter studies to further define proper guidelines.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Arbustini, E (author)
  • Loeys, B (author)
  • Bjorck, EKarolinska Institutet (author)
  • Murphy, L (author)
  • Groenink, M (author)
  • Kempers, M (author)
  • Timmermans, J (author)
  • Roos-Hesselink, J (author)
  • Benke, K (author)
  • Pepe, G (author)
  • Mulder, B (author)
  • Szabolcs, Z (author)
  • Teixido-Tura, G (author)
  • Robert, L (author)
  • Emmanuel, Y (author)
  • Evangelista, A (author)
  • Pini, A (author)
  • von Kodolitsch, Y (author)
  • Jondeau, G (author)
  • De Backer, J (author)
  • Karolinska Institutet (creator_code:org_t)

Related titles

  • In:Orphanet journal of rare diseases: Springer Science and Business Media LLC14:1, s. 264-1750-1172

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view